| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |